Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AXSM
Stock Latest News
Ratings
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
16d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target lowered to $280 from $281 at Deutsche Bank
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $267 from $255 at Needham
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $242 from $217 at Morgan Stanley
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $302 from $242 at RBC Capital
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $310 from $228 at Mizuho
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $246 from $241 at Baird
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $290 from $270 at H.C. Wainwright
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $276 from $239 at BofA
20d ago
AXSM
Premium
Ratings
Buy Rating Reiterated as Auvelity’s Expanded Alzheimer’s Opportunity Drives Upgraded $276 Price Target
20d ago
AXSM
Premium
Company Announcements
Axsome Therapeutics Earnings Call Signals Aggressive Growth
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $280 from $250 at Oppenheimer
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics management to meet with Needham
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics management to meet with Piper Sandler
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $260 from $245 at Guggenheim
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $258 from $223 at Piper Sandler
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $272 from $234 at Cantor Fitzgerald
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $275 from $245 at Jefferies
20d ago
AXSM
Premium
The Fly
Morning Movers: Global Business Travel surges after $6.3B take-private deal
21d ago
AMD
GME
Premium
The Fly
Axsome Therapeutics price target raised to $281 from $245 at Deutsche Bank
21d ago
AXSM
Premium
Company Announcements
Axsome Highlights Strong Q1 Growth and AUVELITY Expansion
21d ago
8K
AXSM
Premium
The Fly
Axsome Therapeutics reports Q1 EPS ($1.26), consensus (86c)
21d ago
AXSM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
